EFGCP Switches Annual Congress from January to March
The European Forum for GCP (EFGCP) has moved its annual two-day conference from the traditional slot in late January to the beginning of March.
Under the title of “Bringing together the two worlds of medicine & device research to better serve public, patients & research participants,” EFGCP Annual Conference 2016 will take place on March 1 and 2, in Brussels, Belgium.
The aim of the event is to help the two worlds of pharma and medical devices develop research, medicines and equipment for patient benefit.
“The EU Medical Device regulations are almost upon us. These will have significant consequences, similar to the Clinical Trail Regulations and there is an opportunity to learn from pharma experience,” noted EFGCP in a statement issued October 1.
The meeting will outline what regulations will mean to the devices industry and focus on the lessons learnt from experience with the clinical trial regulations. The tangible outcomes will be an EFGCP report and recommendations that will be provided to those involved in the legislative process.
For 22 years the European Forum for Good Clinical Practice has acted as a forum to bring patients, researchers, sponsors, competent authorities and ethics committees together and debate current topics. It is recognized as an important forum for multi-stakeholder debate.
SOUL Trial Shows Oral Semaglutide Significantly Reduces Cardiovascular Risk in Type 2 Diabetes
April 3rd 2025Phase III SOUL trial shows daily oral semaglutide lowers the risk of major adverse cardiovascular events in patients with type 2 diabetes and atherosclerotic cardiovascular disease or chronic kidney disease, with benefits consistent with injectable semaglutide and other GLP-1 receptor agonists.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
Phase III Trial Data Show Subcutaneous Pembrolizumab as Noninferior to IV Keytruda
March 31st 2025Subcutaneous administration of pembrolizumab with chemotherapy demonstrated a nearly 50% reduction in patient chair and treatment room time while maintaining efficacy and safety endpoints compared to intravenous Keytruda.
